Abstract
Innovation is essential for the success of any pharmaceutical organization, and Contract Development and Manufacturing Organizations (CDMOs) are “innovation drivers” for major pharmaceutical companies. CDMOs “Execute the Innovation Plan” by collaborating closely with pharmaceutical companies to understand their unique needs and offer tailored solutions through prioritizing customer service. CDMOs can drive industry growth and innovation by enabling pharmaceutical companies to bring new drugs to market faster and more efficiently through access to advanced technology partnerships, flexible and scalable manufacturing solutions, and collaborative customer service. A culture of service is crucial in the contract development and manufacturing organization (CDMO) industry as it directly impacts innovation. The ability to innovate and provide solutions that meet customers’ unique needs differentiates successful CDMOs from the rest. This article explores the role of a culture of service in driving innovation in the CDMO industry.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
